Fortive Corporation – Consensus Indicates Potential 8.0% Upside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Fortive Corporation found using ticker (FTV) have now 16 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 87 and 63 and has a mean target at 73.33. Now with the previous closing price of 67.89 this now indicates there is a potential upside of 8.0%. The 50 day MA is 66.78 and the 200 moving average now moves to 63.29. The market capitalisation for the company is $23,724m. Visit the company website at: https://www.fortive.com

The potential market cap would be $25,625m based on the market concensus.

Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Intelligent Operating Solutions segment provides advanced instrumentation, software and services, which includes electrical test and measurement, facility and asset lifecycle software applications, and worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. Additionally, it markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. Its Precision Technologies segment provides electrical test & measurement, sensing and material technologies under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries. Advanced Healthcare Solutions segment offers critical workflow solutions including instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. The company was incorporated in 2015 and is headquartered in Everett, Washington.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search